Primary and secondary resistance in colorectal cancer
21 May 2012
Primary and secondary resistance in colorectal cancer
Analysis of thirty years of clinical trial data
Infectious diseases as a cause of cancer
Aspirin for the elderly to reduce cancer risk
Update on aspirin and cancer prevention
Evidence for use of aspirin to prevent cancer
Aspirin and cancer - the patient voice
Key gastrointestinal cancer research from EMCC 2011
Advances in the treatment of rectal cancer
Use of circulating tumour cells as a prognostic or predictive marker
Aflibercept vs placebo and FOLFIRI for MCRC
Roundup of the EMCC 2011 conference